Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Journal of Biotechnology ; (12): 95-106, 2013.
Artículo en Chino | WPRIM | ID: wpr-233266

RESUMEN

We evaluated the anti-HBV effects of nucleotide analogues, Entecavir (ETV) and Lamivudine (LAM) targeting mouse model of HBV persistent infection with recombinant adeno-associated virus 8 carrying 1.3 copies of HBV genome (rAAV8-1.3HBV). Ninety percent (27 of 30 mice) of rAAVS-treated mice were chosen as mouse model. Four groups were orally administrated with different doses of ETV (1 mg/(kgd) or 0.1 mg/(kgd)) and LAM (500 mg/(kgd) or 100 mg/(kgd)) once a day for 10 days. The other two groups were set as normal saline treated and untreated control. We detected the levels of HBV DNA, HBeAg and HBsAg in sera at different time. Results indicate that HBV DNA level decreased significantly (P < 0.05) in drug-treated groups compared with normal saline group after drug administration. Fifteen days after the drug withdrawal, HBV DNA level rebounded back obviously (P < 0.05) in groups with low doses of ETV and LAM. However, there was no apparent change of HBeAg and HBsAg in the whole process among all groups. These results showed that our model could reflect the anti-viral effect of nucleotide analogues. This model can be a useful and convenient tool for anti-HBV drug discovery.


Asunto(s)
Animales , Ratones , Antivirales , Farmacología , Dependovirus , Genética , Metabolismo , Modelos Animales de Enfermedad , Vectores Genéticos , Genoma Viral , Guanina , Farmacología , Anticuerpos contra la Hepatitis B , Sangre , Virus de la Hepatitis B , Genética , Fisiología , Hepatitis B Crónica , Virología , Lamivudine , Farmacología , Ratones Endogámicos C57BL , Nucleótidos , Farmacología , Transducción Genética , Replicación Viral
2.
Chinese Journal of Biotechnology ; (12): 1236-1244, 2012.
Artículo en Chino | WPRIM | ID: wpr-342401

RESUMEN

To establish an orthotopic transplant mouse model of hepatocellular carcinoma (HCC) labeled with secretary luciferase and to study its response to anti-tumor treatment with interferon-beta gene therapy. We labeled the murine hepatoma Hepal-6 cells with secretary Gaussia princeps luciferase (Gluc), and then injected Gluc labeled Hepal-6 cells intrasplenically in C57BL/6 mice. We monitored blood Glue to evaluate the tumor development and anti-tumor effects of hydrodynamic injection with interferon-beta expressing plasmid. We successfully established the orthotopic mouse model of HCC by intrasplenic injection of Glue labeled Hepal-6 cells. The Glue blood assay could reflect the amount of cancer cells in vivo, tumor progression, as well as anti-tumor effect of interferon-beta gene therapy. In conclusion, Gluc labeled orthotopic transplant mouse model of HCC can ex vivo real-time monitor the tumor development and tumor response to treatments.


Asunto(s)
Animales , Ratones , Carcinoma Hepatocelular , Patología , Terapéutica , Línea Celular Tumoral , Genes Reporteros , Terapia Genética , Interferón beta , Genética , Usos Terapéuticos , Neoplasias Hepáticas , Patología , Terapéutica , Luciferasas , Sangre , Genética , Secreciones Corporales , Ratones Endogámicos C57BL , Trasplante de Neoplasias , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA